Reduced left ventricular functional reserve in hypertensive patients with preserved function at rest

Michaela Kozakova1, Alan G Fraser, Simona Buralli

  • 1Department of Internal Medicine, University of Pisa School of Medicine, Italy.

Insights

Hypertension can cause subtle heart muscle problems, even when resting function appears normal. Low-dose dobutamine stress testing reveals impaired myocardial functional reserve in hypertensive patients, linked to increased left ventricular wall thickness.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Hypertension Research

Background:

  • Hypertensive patients often exhibit normal resting left ventricular pump function, but abnormal function during exercise.
  • Potential causes include myocardial dysfunction or altered left ventricular loading.
  • This study investigates impaired myocardial functional reserve in the hypertensive heart.

Purpose of the Study:

  • To assess stress-adjusted midwall shortening response to dobutamine infusion in hypertensive individuals with normal resting function.
  • To identify subtle myocardial dysfunction masked at rest.
  • To explore the relationship between this dysfunction and cardiac structural changes.

Main Methods:

  • Sixty-five subjects (45 hypertensive, 20 normotensive) received graded low-dose dobutamine (1-5 microg x kg(-1) x min(-1)).
  • Echocardiography (2D, M-mode, Doppler) assessed cardiac function at baseline and during infusion.
  • Midwall shortening response to dobutamine was analyzed, defining a normal response based on control group data.

Main Results:

  • Normotensive controls showed a significant increase in midwall shortening with dobutamine.
  • Hypertensive subjects were divided into normal (Group I) and subnormal (Group II) responders.
  • Group II (subnormal response) had greater left ventricular relative wall thickness than Group I, despite similar blood pressure and mass.

Conclusions:

  • Very-low-dose dobutamine unmasks subtle impairment of myocardial functional reserve in hypertensive patients with normal resting function.
  • This myocardial dysfunction is associated with increased left ventricular relative wall thickness.
  • Hypertension-induced cardiac alterations can affect functional reserve even before resting dysfunction is apparent.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...